Veeva announces new app to speed up validation execution


PLEASANTON, California, September 15, 2021 / PRNewswire / – Veeva Systems (NYSE: VEEV) announced today Managing Veeva Vault validation, a new application that will allow a more efficient and economical management of the validation lifecycle. Life science companies will be able to create and organize validation activities, manage a global library of test scripts, and run and record validation data electronically for faster test execution. and greater compliance.

“Manual validation processes are inefficient, drain resources and increase operational costs,” said Mike Jovanis, vice president of Veeva Vault Quality. “Veeva Vault Validation Management will enable customers to optimize the end-to-end validation lifecycle with paperless execution for increased efficiency and audit readiness.

Vault Validation Management will reduce manual processes and eliminate silos for better tracking and alignment between validation activities and projects. Quality teams will be able to use artifacts and suggested models to ensure consistency, ensuring good documentation practices (BPD) and data integrity.

Seamless integration with Veeva Vault QualityDocs and Veeva Vault Quality Management System will connect key artifacts, variances and change controls, improving data transparency and accessibility. Intuitive dashboards also display critical metrics such as status and cycle times for better traceability across validation projects.

The management of the safe validation is part of the Veeva Vault quality suite, including Vault QMS, Vault QualityDocs, Veeva Vault training, Veeva LearnGxP, Station Manager Veeva Vault, and Monitoring Veeva Vault products to automate and harmonize quality processes globally. Vault Quality Suite makes it easy for businesses to manage quality in a unified solution and delivers the power and scalability needed across the life sciences value chain.

Vault Validation Management is expected to be available in the second half of 2022. To learn more about Vault Validation Management, visit veeva.com/VaultValidationManagement.

To assist Veeva R&D and Quality Summit Connect to October 14, 2021 to learn more about the new offering, Merck & Co., Inc.’s digital quality transformation journey, and Supernus Pharmaceuticals’ organizational change management best practices for quality modernization. The online event is open to professionals in the life sciences industry. Sign up and stay informed of program details at veeva.com/Summit.

Additional information
Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems
Follow @veevasystems on Twitter: twitter.com/veevasystems

About Veeva Systems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence and customer success, Veeva serves more than 1,100 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechnology. As a public interest company, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders and the industries it serves. For more information visit veeva.com.

Forward-looking statements
This release contains forward-looking statements, including market demand and acceptance of Veeva’s products and services, results of use of Veeva’s products and services, and general business conditions, particularly in the science industry. life. All forward-looking statements contained in this press release are based on the historical performance of Veeva and its current plans, estimates and expectations, and do not constitute a representation that such plans, estimates or expectations will be realized. These forward-looking statements represent Veeva’s expectations as of the date of this press release. Subsequent events may change these expectations and Veeva disclaims any obligation to update any forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties which could cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva’s financial results are included under “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the Company’s filing on the Form 10-Q for the period ended July 31. , 2021. This is available on the company’s website at veeva.com in the Investors section and on the SEC website at sec.gov. Further information on potential risks that could affect actual results will be included in other documents filed by Veeva with the SEC from time to time.

Contact:

Deivis Mercado
Veeva Systems
925-226-8821
[email protected]

SOURCE Veeva Systems

Related links

http://www.veeva.com



Leave a Reply

Your email address will not be published.